Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry

New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy

(2016) Frieder Braunschweig et al.   EUROPEAN JOURNAL OF HEART FAILURE

Use of evidence-based therapy and survival in heart failure in Sweden 2003-2012

(2016) Tonje Thorvaldsen et al.   EUROPEAN JOURNAL OF HEART FAILURE

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

(2016) Piotr Ponikowski et al.   EUROPEAN JOURNAL OF HEART FAILURE

Baseline Functional Class and Therapeutic Efficacy of Common Heart Failure Interventions: A Systematic Review and Meta-analysis

(2015) Robert J.H. Miller et al.   CANADIAN JOURNAL OF CARDIOLOGY

Statistics on the use of cardiac electronic devices and electrophysiological procedures in the European Society of Cardiology countries: 2014 report from the European Heart Rhythm Association

(2015) M. J. P. Raatikainen et al.   EUROPACE

Individual patient data network meta-analysis of mortality effects of implantable cardiac devices

(2015) B Woods et al.   HEART

Heart Failure in Non-Caucasians, Women, and Older Adults: A White Paper on Special Populations From the Heart Failure Society of America Guideline Committee

(2015) Monica Colvin et al.   JOURNAL OF CARDIAC FAILURE

Does Age Influence Cardiac Resynchronization Therapy Use and Outcome?

(2015) Paul A. Heidenreich et al.   JACC-Heart Failure

Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure

(2014) C. Linde et al.   EUROPACE

European Cardiac Resynchronization Therapy Survey II: rationale and design

(2014) Kenneth Dickstein et al.   EUROPACE

Awareness of indications for device therapy among a broad range of physicians: a survey study

(2014) Clara Hübinette et al.   EUROPACE

Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14 713 patients in the Swedish Heart Failure Registry

(2014) Lars H. Lund et al.   EUROPEAN JOURNAL OF HEART FAILURE

On the Underutilization of Cardiac Resynchronization Therapy

(2014) Alan J. Bank et al.   JOURNAL OF CARDIAC FAILURE

Cardiac Resynchronization Therapy in Women

(2014) Robbert Zusterzeel et al.   JAMA Internal Medicine

Temporal Trends in Treatment and Outcomes for Advanced Heart Failure With Reduced Ejection Fraction From 1993–2010

(2013) John C. Loh et al.   Circulation-Heart Failure

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

(2013) J. G. Cleland et al.   EUROPEAN HEART JOURNAL

Women have better long-term prognosis than men after cardiac resynchronization therapy

(2012) S. Zabarovskaja et al.   EUROPACE

Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction

(2012) Lars H. Lund et al.   EUROPEAN HEART JOURNAL

Association Between Use of Renin-Angiotensin System Antagonists and Mortality in Patients With Heart Failure and Preserved Ejection Fraction

(2012) Lars H. Lund et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

External review and validation of the Swedish national inpatient register

(2011) Jonas F Ludvigsson et al.   BMC PUBLIC HEALTH

The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades

(2011) Nigussie Bogale et al.   EUROPEAN JOURNAL OF HEART FAILURE

The European CRT Survey: 1 year (9-15 months) follow-up results

(2011) Nigussie Bogale et al.   EUROPEAN JOURNAL OF HEART FAILURE